Ueyama E - Search Results

1

Systematic expression of immediate early genes and intensive astrocyte activation induced by intrastriatal ferrous iron injection.

Hironishi M, Ueyama E, Senba E. Hironishi M, et al. Among authors: ueyama e. Brain Res. 1999 May 15;828(1-2):145-53. doi: 10.1016/s0006-8993(99)01356-6. Brain Res. 1999. PMID: 10320734

2

Fasting-induced activation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus.

Morikawa Y, Ueyama E, Senba E. Morikawa Y, et al. Among authors: ueyama e. J Neuroendocrinol. 2004 Feb;16(2):105-12. doi: 10.1111/j.0953-8194.2004.01135.x. J Neuroendocrinol. 2004. PMID: 14763996

3

Attenuation of fasting-induced phosphorylation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus in response to refeeding.

Ueyama E, Morikawa Y, Yasuda T, Senba E. Ueyama E, et al. Neurosci Lett. 2004 Nov 16;371(1):40-4. doi: 10.1016/j.neulet.2004.08.035. Neurosci Lett. 2004. PMID: 15500963

4

Molecular cloning of a cDNA encoding mouse A15, a member of the transmembrane 4 superfamily, and its preferential expression in brain neurons.

Hosokawa Y, Ueyama E, Morikawa Y, Maeda Y, Seto M, Senba E. Hosokawa Y, et al. Among authors: ueyama e. Neurosci Res. 1999 Dec 30;35(4):281-90. doi: 10.1016/s0168-0102(99)00093-0. Neurosci Res. 1999. PMID: 10617319

5

[Repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats].

Ueyama E, Ukai S, Ogawa A, Yamamoto M, Kawaguchi S, Ishii R, Shinosaki K. Ueyama E, et al. Seishin Shinkeigaku Zasshi. 2012;114(9):1018-22. Seishin Shinkeigaku Zasshi. 2012. PMID: 23289164 Japanese. No abstract available.

6

Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats.

Ueyama E, Ukai S, Ogawa A, Yamamoto M, Kawaguchi S, Ishii R, Shinosaki K. Ueyama E, et al. Psychiatry Clin Neurosci. 2011 Feb;65(1):77-81. doi: 10.1111/j.1440-1819.2010.02170.x. Psychiatry Clin Neurosci. 2011. PMID: 21265939 Free article.

7

Analysis of Pediatric Drug Approval Lag in Japan.

Ueyama E, Kaneko M, Narukawa M. Ueyama E, et al. Ther Innov Regul Sci. 2021 Mar;55(2):336-345. doi: 10.1007/s43441-020-00218-z. Epub 2020 Sep 21. Ther Innov Regul Sci. 2021. PMID: 32959206

8

Pediatric Drug Development in Japan: A Comparison of the Current Situation and Characteristics Between Japan and Europe.

Ueyama E, Kaneko M, Narukawa M. Ueyama E, et al. Ther Innov Regul Sci. 2020 Sep;54(5):1152-1158. doi: 10.1007/s43441-020-00136-0. Epub 2020 Mar 4. Ther Innov Regul Sci. 2020. PMID: 32865796

9

Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus.

Saito M, Kaibara A, Kadokura T, Toyoshima J, Yoshida S, Kazuta K, Ueyama E. Saito M, et al. Among authors: ueyama e. Diabetes Ther. 2020 Apr;11(4):951-964. doi: 10.1007/s13300-020-00785-2. Epub 2020 Mar 12. Diabetes Ther. 2020. PMID: 32166619 Free PMC article.

10

Pharmacokinetic and pharmacodynamic modelling for renal function dependent urinary glucose excretion effect of ipragliflozin, a selective sodium-glucose cotransporter 2 inhibitor, both in healthy subjects and patients with type 2 diabetes mellitus.

Saito M, Kaibara A, Kadokura T, Toyoshima J, Yoshida S, Kazuta K, Ueyama E. Saito M, et al. Among authors: ueyama e. Br J Clin Pharmacol. 2019 Aug;85(8):1808-1819. doi: 10.1111/bcp.13972. Epub 2019 Jun 20. Br J Clin Pharmacol. 2019. PMID: 31026084 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters